Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology and Natural History of Nephrolithiasis

  • Original Paper
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

The epidemiology and natural history of nephrolithiasis comprise its incidence and prevalence; role of age, gender, and race; risk factors, comorbidities, and course. As such, epidemiology verges into clinical features, pathogenesis, treatment, and prognosis. Although it is well known that associations derived from epidemiological studies do not prove causal relationships, lessons from epidemiology and natural history have been readily applied to pathogenesis and treatment. Conversely, knowledge derived from experiment and interventional trials has furnished models for understanding epidemiological data. Hence, it is not easy to divide epidemiology from other aspects of nephrolithiasis. While my primary emphasis in this review will be on epidemiological studies, I will consider other kinds of studies that help us to understand the epidemiology and natural history of nephrolithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–52.

    Article  PubMed  CAS  Google Scholar 

  2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.

    Article  PubMed  Google Scholar 

  3. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–93.

    Article  PubMed  Google Scholar 

  4. Soucie JM, Thun MJ, Coates RJ, McClennan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–9.

    Article  PubMed  CAS  Google Scholar 

  5. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(suppl 3):S45–50.

    PubMed  Google Scholar 

  6. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.

    PubMed  Google Scholar 

  7. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 and 2000. Eur Urol. 2003;44:709–13.

    Article  PubMed  CAS  Google Scholar 

  8. Akoudad S, Szklo M, McAdams MA, Fulop T, Anderson CA, Coresh J, Kottgen A. Correlates of kidney stone disease differ by race in a multi-ethnic middle aged population: the ARIC Study. Prev Med. 2010;51:416–20.

    Article  PubMed  Google Scholar 

  9. Lieske JC, de la Pena Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760–4.

    Article  PubMed  CAS  Google Scholar 

  10. Jr Scales Cd, Curtis LH, Norrias RD, Springhart P, Sur RL, Shulman KA, Preminger GM. Changing gender prevalence of stone disease. J Urol. 2007;177:979–82.

    Article  PubMed  Google Scholar 

  11. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epid. 1996;143:487–95.

    CAS  Google Scholar 

  12. Blacklock NJ. The pattern of urolithiasis in the Royal Navy. In Hodgkinson A, Nordin BE, eds. Renal stone research symposium. London:Churchill 1969;33–47.

  13. Pugliese JM, Baker KC. Epidemiology of nephrolithiasis in personnel returning fromn Operation Iraqi Freedom. Urology. 2009;74:56–61.

    Article  PubMed  Google Scholar 

  14. Parry ES, Lister IS. Sunlight and hypercalciuria. Lancet. 1975;10:1063–5.

    Article  Google Scholar 

  15. Elomaa I, Karonen SL, Kairento AL, Pelkonen R. Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation. Scand J Urol Nephrol. 1982;16:155–61.

    Article  PubMed  CAS  Google Scholar 

  16. Fakheri RJ, Goldfarb D. Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis. Kidney Int. 2009;76:798.

    Article  PubMed  Google Scholar 

  17. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci. 2008;105:9841–6.

    Article  PubMed  CAS  Google Scholar 

  18. Coe F, Keck J, Norton ER. The natural history of calcium nephrolithiasis. JAMA. 1977;238:1519–23.

    Article  PubMed  CAS  Google Scholar 

  19. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol. 1984;56:122–4.

    Article  PubMed  CAS  Google Scholar 

  20. Ahlstrand C, Tisleius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res. 1990;18:397–9.

    Article  PubMed  CAS  Google Scholar 

  21. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999;162:27–30.

    Article  PubMed  CAS  Google Scholar 

  22. Pak CY. Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol. 1982;127:855–8.

    PubMed  CAS  Google Scholar 

  23. Hosseini MM, Eshragian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: comparison with of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol. 2010;42:127–31.

    Article  PubMed  Google Scholar 

  24. Yagisawa T, Chandhoke PS, Fan J. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urol. 1998;52:750–5.

    Article  PubMed  CAS  Google Scholar 

  25. Glowacki LS, Beecroft ML, Cook RJ, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319–21.

    PubMed  CAS  Google Scholar 

  26. Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534–9.

    Article  PubMed  Google Scholar 

  27. Inci K, Sahin A, Islamoglu E, Eren MT, Bakkaloglu M, Ozen H. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007;177:2189–92.

    Article  PubMed  Google Scholar 

  28. Keeley FX Jr, Tilling K, Elves A, Menezes P, Wills P, Rao N, Fenely R. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. B JU Int. 2001;87:1–8.

    Google Scholar 

  29. Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol. 1976;115:505–6.

    PubMed  CAS  Google Scholar 

  30. Rous SN, Turner WR. Retrospective study of 95 patients with staghorn calculus disease. J Urol. 1977;118:902–4.

    PubMed  CAS  Google Scholar 

  31. Vargas AD, Bragin SD, Mendez R. Staghorn calculus: its clinical presentation, complications, and management. J Urol. 1982;127:860–2.

    PubMed  CAS  Google Scholar 

  32. Keoghane S, Walmsley B, Hodgson D. The natural history of untreated renal tract calculi. BJU Int. 2010;105:1627–31.

    Article  PubMed  Google Scholar 

  33. Candau C, Saussine C, Lang H, Roy C, Faure F, Jacqmin D. Natural history of residual renal stone fragments after ESWL. Eur Urol. 2000;37:18–22.

    Article  PubMed  CAS  Google Scholar 

  34. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G. Frammenti residui clinicamente insignificanti (CIRF) dopo litotrissia extracorporea: implicazioni e trattamento. J Urol. 1994;151:5–9.

    PubMed  CAS  Google Scholar 

  35. Mollerup CL, Lindewald H. Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg. 1999;23:173–5.

    Article  PubMed  CAS  Google Scholar 

  36. Better OS, Shabtai M, Kedar S, Melamud A, Berenheim J, Chaimovitz C. Increased incidence of nephrolithiasis in lifeguards in Israel. Adv Exp Med Biol. 1980;128:467–72.

    PubMed  CAS  Google Scholar 

  37. Atan L, Andreoni C, Ortiz V, Silva EK, Pitta R, Atan F, Srougi M. High kidney stone risk in men working in steel industry at hot temperatures. Urology. 2005;65:858–61.

    Article  PubMed  Google Scholar 

  38. Borghi L, Meschi T, Amato F, Novarini A, Romanelli A, Cigala F. Hot occupation and nephrolithiasis. J Urol. 1993;150:1757–60.

    PubMed  CAS  Google Scholar 

  39. Chauhan V, Eskin B, Allegra JR, Cochrane DG. Effect of season, age, and gender on renal colic incidence. Am J Emerg Med. 2004;22:560–3.

    Article  PubMed  Google Scholar 

  40. Cervellin G, Comelli I, Comelli D, Cortellini P, Lippi G, Meschi T, Borghi L. Regional short-term climate variations influence on the number of visits for renal colic in a large urban emergency department: results of a 7-year survey. Intern Emerg Med. 2011;6:141–7.

    Article  PubMed  Google Scholar 

  41. Baker PW, Covie P, Bais R, Rofe AM. Influence of season, age, and sex on renal stone formation in South Australia. Med J Aust. 1993;159:390–2.

    PubMed  CAS  Google Scholar 

  42. al-Hydramy MS. Seasonal variations of urinary stone colic in Arabia. J Pak Med Assoc. 1997;47:281–4.

    Google Scholar 

  43. Vezzoli G, Terranegra A, Arcidiacono T, Soldati L. Genetics and calcium nephrolithiasis. Kidney Int 2010;epub ahead of print, Accessed 5/26/2011.

  44. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–73.

    PubMed  CAS  Google Scholar 

  45. Edvardsson VO, Palsson R, Indradason OS, Thorvaldsson S, Steffanson K. Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol. 2009;43:420–4.

    Article  PubMed  Google Scholar 

  46. Koyuncu H, Yencilek F, Eryildirim B, Sarica K. Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence? Urol Res. 2010;38:105–9.

    Article  PubMed  Google Scholar 

  47. Basiri A, Shakhssalim N, Khoshdel AR, Javaherforooshzadeh A, Basiri H, Radfar MH, Dorraj N. Familial relations and recurrence pattern in nephrolithiasis. Urol J. 2010;7:81–6.

    PubMed  Google Scholar 

  48. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300:337–40.

    Article  PubMed  CAS  Google Scholar 

  49. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517–23.

    Article  PubMed  CAS  Google Scholar 

  50. Ferreira LG, Pereira AC, Heilberg IP. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients. Nephron Clin Pract. 2010;114:c135–44.

    Article  PubMed  CAS  Google Scholar 

  51. Thorleifsson G, Holm H, Edvardsson V, et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet. 2009;412:926–30.

    Article  CAS  Google Scholar 

  52. Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993;22:513–9.

    PubMed  CAS  Google Scholar 

  53. Fick GM, Gabow PA. Hereditary and acquired cystic disease of the kidney. Kidney Int. 1994;46:951–64.

    Article  PubMed  CAS  Google Scholar 

  54. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008;17:304–9.

    Article  PubMed  Google Scholar 

  55. Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R, Sergeant V, Smith A. Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol. 1983;55:595–8.

    Article  PubMed  CAS  Google Scholar 

  56. Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A. Essential arterial hypertension and stone disease. Kidney Int. 1999;55:2397–406.

    Article  PubMed  CAS  Google Scholar 

  57. Krambeck AE, Rule AD, Li X, Bergstrath EJ, Gettman MT, Lieske JC. Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup. J Urol. 2011;185:164–9.

    Article  PubMed  Google Scholar 

  58. Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9:1645–52.

    PubMed  CAS  Google Scholar 

  59. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62.

    Article  PubMed  CAS  Google Scholar 

  60. Semins M, Shore AD, Makary MA, Magnuson T, Johns R, Matiaga BR. The association of increasing body mass index and kidney stone disease. J Urol. 2010;183:571–5.

    Article  PubMed  Google Scholar 

  61. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res. 2008;36:303–7.

    Article  PubMed  CAS  Google Scholar 

  62. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.

    Article  PubMed  CAS  Google Scholar 

  63. Eisner BH, Eisenberg ML, Stoller ML. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology. 2010;75:1289–93.

    Article  PubMed  Google Scholar 

  64. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–5.

    Article  PubMed  Google Scholar 

  65. Weikert C, Weikert S, Schulze MB, Pischon T, Fritsche A, Bergmann MM, Willich SN, Boeing H. Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epid. 2010;171:447–54.

    Article  Google Scholar 

  66. West B, Luke A, Durazzo-Arvizo RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741–7.

    Article  PubMed  Google Scholar 

  67. Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and subclinical atherosclorosis in young adults: the CARDIA study. J Urol. 2011;185:920–5.

    Article  PubMed  Google Scholar 

  68. DrFronzo R, Cooke CR, Andres CR, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845–55.

    Article  Google Scholar 

  69. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolilthiasis in men: the health professionals’ follow-up study. Kidney Int. 2003;64:1022–6.

    Article  PubMed  Google Scholar 

  70. Rule AD, Roger VL, Melton LJ III, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21:1641–4.

    Article  PubMed  Google Scholar 

  71. Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171:1024–920.

    Article  Google Scholar 

  72. Teichman JM, Long RD, Hulbert RC. Long-term renal fate and prognosis after staghorn calculus management. J Urol. 1995;153:1403–7.

    Article  PubMed  CAS  Google Scholar 

  73. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis. 2004;44:799–805.

    PubMed  Google Scholar 

  74. Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804–11.

    Article  PubMed  Google Scholar 

  75. Saucier NA, Sinha MK, Liang KV, et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmstead County, Minnesota. Am J Kidney Dis. 2010;55:61–8.

    Article  PubMed  Google Scholar 

  76. Marangella M, Bruno M, Cosseddu D, Manganaro M, Tricerri A, Vitale C, Linari F. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990;54:302–6.

    Article  PubMed  CAS  Google Scholar 

  77. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Intl. 2007;71:1000–7.

    Google Scholar 

  78. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after modern bariatric surgery. J Urol. 2008;181:161–6.

    Article  PubMed  Google Scholar 

  79. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.

    Article  PubMed  CAS  Google Scholar 

  80. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497–504.

    PubMed  CAS  Google Scholar 

  81. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women. Arch Intern Med. 2004;164:885–91.

    Article  PubMed  Google Scholar 

  82. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225–532.

    Article  PubMed  Google Scholar 

  83. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol 4;1980–1987.

  84. Norman DA, Fordtran LJ, Brinkley LJ, Zerwekh JE, Nicar MJ, Strowig SM, Pak CY. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1, 25-dihydroxyvitamin D. J Clin Invest. 1981;67:1599–603.

    Article  PubMed  CAS  Google Scholar 

  85. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77–84.

    Article  PubMed  CAS  Google Scholar 

  86. Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CY. Effect of dietary calcium on stone forming propensity. J Urol. 2003;169:470–4.

    Article  PubMed  CAS  Google Scholar 

  87. Wallace RB, Wactawski-Wende O’Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K. Urinary tract stone occurrence in the women’s health initiative randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011; April 27 (epub ahead of print).

  88. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198–204.

    Article  PubMed  CAS  Google Scholar 

  89. Holmes PR, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270–6.

    Article  PubMed  CAS  Google Scholar 

  90. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol. 1999;2(suppl 14):S329–33.

    Google Scholar 

  91. Lieske JC, Tremaine WJ, DeSimone C, O’Connor HM, Li X, Bergstralh EJ, Goldfarb D. Diet, not not oral probiotics, effectively reduces urine oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010;78:1178–11185.

    Article  PubMed  CAS  Google Scholar 

  92. Wasserstein AG. Lessons in medical humanism: the case of Montaigne. Ann Intern Med. 2007;146:809–13.

    PubMed  Google Scholar 

  93. Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci. 1997;9(57):285–8.

    Google Scholar 

  94. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140–6.

    Article  PubMed  CAS  Google Scholar 

  95. Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Epidemiological risk factors in calcium stone disease. Scand J Urol Nephrol. 1980;53(suppl):15–30.

    CAS  Google Scholar 

  96. Peacock M, Nordin BEC. Hypercalciuria of renal stone disease. In Hodgkinson, A, Nordin BEC., eds.Proceedings of the renal stone research symposium. London:Livingtons, 1969;253–261.

  97. O’Dwyer JT. Health aspects of vegetarian diets. Am J Clin Nutr. 1988;48:712–38.

    Google Scholar 

  98. Wasserstein AG, Stolley PD, Soper KA, Goldfarb S, Maislin G, Agus Z. A case-control study of risk factors for idiopathic calcium nephrolithiasis. Mineral Elect Metab. 1987;13:85–95.

    CAS  Google Scholar 

  99. Graces F, Costa-Bauza A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res. 1999;19:3717–22.

    Google Scholar 

  100. Graces F, Garcia-Gonzales R, Torres JJ, Llobera A. Effects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol. 1998;32:261–5.

    Article  Google Scholar 

  101. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20:2253–9.

    Article  PubMed  CAS  Google Scholar 

  102. Taylor EN, Stampfer MJ, Mount DB, Curhan GC. DASH-style diet and 24-hour urine composition. Clin J Am Soc Nephrol. 2010;5:2315–22.

    Article  PubMed  CAS  Google Scholar 

  103. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402–10.

    Article  PubMed  CAS  Google Scholar 

  104. Taylor EN, Curhan GC. Role of nutrition in the formation of calcium-containing kidney stones. Nephron Physiol. 2004;98:55–63.

    Article  CAS  Google Scholar 

  105. Ebisuno S, Morimoto S, Yasukawa S, Ohkawa T. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients. Br J Urol. 1991;67:237–40.

    Article  PubMed  CAS  Google Scholar 

  106. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and kidney stone risk. Nutr Rev. 1995;53:131–9.

    Article  PubMed  CAS  Google Scholar 

  107. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993;150:310–2.

    PubMed  CAS  Google Scholar 

  108. Stoller ML, Chi T, Eisner BH, et al. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol. 2009;181:1140.

    Article  PubMed  Google Scholar 

  109. Eisner BH, Eisenberg ML, Stoller ML. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis. J Urol. 2009;182:2330–3.

    Article  PubMed  CAS  Google Scholar 

  110. Yun SJ, Ha YS, Kim WT, et al. Sodium restriction as initial conservative treatment for urinary stone disease. J Urol. 2010;184:1372–6.

    Article  PubMed  CAS  Google Scholar 

  111. Nouvenne A, Meschi T, Prati B, Guerra A, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010;91:565–70.

    Article  PubMed  CAS  Google Scholar 

  112. Thom JA, Morris JE, Bishop A, Blacklock NJ. The influence of refined carbohydrate on urinary calcium excretion. Br J Urol. 1978;50:459–64.

    Article  PubMed  CAS  Google Scholar 

  113. Iguchi M, Umekawa T, Takamura C, et al. Glucose metabolism in renal stone patients. Urol Int. 1993;51:185–90.

    Article  PubMed  CAS  Google Scholar 

  114. Power C, Barker DJ, Nelson M, Winter PD. Diet and renal stones: a case-control study. Br J Urol. 1984;56:456–9.

    PubMed  CAS  Google Scholar 

  115. Knight J, Assimos DG, Easter L, Holmes RP. Metabolism of fructose to oxalate and glycolate. Hormone Metab Res. 2010;42:868–73.

    Article  CAS  Google Scholar 

  116. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240–7.

    PubMed  CAS  Google Scholar 

  117. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128:534–40.

    PubMed  CAS  Google Scholar 

  118. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.

    Article  PubMed  CAS  Google Scholar 

  119. Honow R, Laube N, Schneider A, Kessler T, Hesse A. Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. Br J Nutr. 2003;90:295–300.

    Article  PubMed  CAS  Google Scholar 

  120. Trinchieri A, Lizzano R, Bernardini P, et al. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Dig Liver Dis. 2002;34(Suppl 2):S160–3.

    Article  PubMed  Google Scholar 

  121. Shuster J, Finlayson B, Scheaffer RL, Sierakowski R, Zoltek J, Dzegede S. Primary liquid intake and urinary stone disease. J Chron Dis. 1985;38:907–14.

    Article  PubMed  CAS  Google Scholar 

  122. Shuster J, Jenkins A, Logan C, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911–6.

    Article  PubMed  CAS  Google Scholar 

  123. Sweeney DD, Tomaszewski JJ, Ricchiuti DD, Averch T. Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors. J Urol. 2009;182:992–7.

    Article  PubMed  Google Scholar 

  124. Penniston KL, Steele TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in paitents with recurrent calcium oxalate stone formation. Urology. 2007;70:856–60.

    Article  PubMed  Google Scholar 

  125. Koff SG, Paquette EL, Cullen J, et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology. 2007;69:1013–6.

    Article  PubMed  Google Scholar 

  126. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol. 2006;1:1269–74.

    Article  PubMed  CAS  Google Scholar 

  127. Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis. 2005;45:267–74.

    Article  PubMed  CAS  Google Scholar 

  128. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol. 1992;147:1215–8.

    PubMed  CAS  Google Scholar 

  129. Robitaille L, Marner OA, Miller WH Jr, et al. Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism. 2009;58:263–9.

    Article  PubMed  CAS  Google Scholar 

  130. Curhan GC, Willett W, Rimm E, Stampfer MJ. A prospective study of the intake of vitamin C and vitamin B6 and the risk of kidney stones in men. J Urol. 1996;155:1847–51.

    Article  PubMed  CAS  Google Scholar 

  131. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10:840–5.

    PubMed  CAS  Google Scholar 

  132. Penniston KL, Jones AN, Nakada SY, Hansen KE. Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women. BJU Int. 2009;104:1512–6.

    Article  PubMed  CAS  Google Scholar 

  133. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;48:10–8.

    Article  Google Scholar 

  134. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977;87:404–10.

    PubMed  CAS  Google Scholar 

  135. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among men and women. Kidney Int. 2001;59:2290–8.

    PubMed  CAS  Google Scholar 

  136. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Sem Nephrol. 2008;28:120–32.

    Article  CAS  Google Scholar 

  137. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol. 2009;4:1980–7.

    Article  PubMed  CAS  Google Scholar 

  138. Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008;19:1197–203.

    Article  PubMed  CAS  Google Scholar 

  139. Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol. 2008;3:1453–60.

    Article  PubMed  CAS  Google Scholar 

  140. Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG. Urinary citrate and renal stone disease. CMAJ. 1989;141(3):217–21.

    PubMed  CAS  Google Scholar 

  141. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386–9.

    Article  PubMed  CAS  Google Scholar 

  142. Matiaga BR, Schaeffer AJ, Novak TE, Trock BJ. Epidemiologic insights into pediatric kidney stone disease. Urol Res. 2010;38:453–7.

    Article  Google Scholar 

  143. Spivacow FR, Negri AL, del Valle EE, et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008;23:1129–33.

    Article  PubMed  Google Scholar 

  144. VanDervoort K, Wiesen J, Frank R, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177:2300–5.

    Article  PubMed  Google Scholar 

  145. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010;157:32–137.

    Article  Google Scholar 

  146. Kalorin CM, Zabinski A, Okpareke I, et al. Pediatric stone disease–does age matter? J Urol. 2009;181:2267–71.

    Article  PubMed  Google Scholar 

  147. Pietrow PK, Pope JCIV, Adams MC, et al. Clinical outcome of pediatric stone disease. J Urol. 2002;167:670–3.

    Article  PubMed  Google Scholar 

  148. DeFoor WR, Jackson E, Minevich E, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010;76:242–5.

    Article  PubMed  Google Scholar 

  149. Alaya A, Nouri A, Najjar MF. Changes in stone composition according to age and gender in Tunisian children. J Ped Urol. 2010;6:364–71.

    Article  CAS  Google Scholar 

  150. Erbaqci A, Erbaqci B, Yilmaz M, et al. Pediatric urolithiasis–evaluation of risk factors in 95 children. Scand J Urol Nephrol. 2003;37:129–33.

    Article  Google Scholar 

  151. Acar B, Inci Arakan F, Emeksiz S, Dallar Y. Risk factors for nephrolithiasis in children. World J Urol. 2008;26:627–30.

    Article  PubMed  Google Scholar 

  152. Schaeffer AJ, Feng Z, Trock BJ, et al. Medical comorbidities associated with pediatric stone disease. Urology. 2011;77:195–9.

    Article  PubMed  Google Scholar 

  153. Schwaderer AL, Cronin R, Mahan JD, Bates CM. Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol. 2008;23:2209–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, 1 Founders, Philadelphia, PA, 19104, USA

    Alan G. Wasserstein

Authors
  1. Alan G. Wasserstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan G. Wasserstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wasserstein, A.G. Epidemiology and Natural History of Nephrolithiasis. Clinic Rev Bone Miner Metab 9, 165–180 (2011). https://doi.org/10.1007/s12018-011-9097-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-011-9097-3

Keywords

Search

Navigation